Uipath Inc Cl A (PATH)
$54.10
0.54 (1.01%)
PATH Stock Quote Delayed 30 Minutes
PATH Stock: 13 Things to Know as UiPath Shares Slump Today
UiPath (PATH) stock is falling hard on Wednesday following the release of its earnings report for the second quarter of fiscal 2022.
Louis Navellier's Top 6 Stocks for 2021
He found Apple at $1.49… Intel at $3.60... Amazon at $46. Now, investing legend Louis Navellier is revealing his Top 6 Stocks for 2021 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
4.16M
Day's Range
53.11 - 54.29
52-Week Range
52.69 - 90.00
Dividend & Yield
N/A (N/A)
PATH Stock Predictions, Articles, and Uipath Inc Cl A News
PATH Stock: 18 Things for Potential UiPath Investors to Know as Shares Begin Trading
UiPath (PATH) stock is set to start trading today and there's plenty that investors need to know about the company before that happens.
UiPath IPO: When Does UiPath Go Public? What Is the PATH Stock IPO Price Range?
The UiPath IPO is quickly approaching. Here is what you need to know about the PATH stock IPO price range and everything else.
7 Pharmaceutical Stocks to Buy Now
Seven pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
8 Pharmaceutical Stocks to Buy Now
This week, eight pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").
8 Pharmaceutical Stocks to Buy Now
Eight pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
7 Pharmaceutical Stocks to Buy Now
The grades of seven pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
6 Pharmaceutical Stocks to Buy Now
The grades of six pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
6 Pharmaceutical Stocks to Buy Now
The grades of six pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
6 Pharmaceutical Stocks to Buy Now
The grades of six pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
6 Pharmaceutical Stocks to Buy Now
Six pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
7 Pharmaceutical Stocks to Buy Now
The grades of seven pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
6 Pharmaceutical Stocks to Buy Now
The grades of six pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
6 Pharmaceutical Stocks to Buy Now
This week, six pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
7 Pharmaceutical Stocks to Buy Now
The grades of seven pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
6 Pharmaceutical Stocks to Buy Now
This week, six pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
6 Pharmaceutical Stocks to Buy Now
The grades of six pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
6 Pharmaceutical Stocks to Buy Now
Six pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
6 Pharmaceutical Stocks to Buy Now
This week, six pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
6 Pharmaceutical Stocks to Buy Now
The grades of six pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
6 Pharmaceutical Stocks to Buy Now
The grades of six pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
